Document:

Douglas
P. Baker	May 12, 2014

  

Dear
Douglas,

 

On
behalf of the executive team here at OPTIMIZERx we are please to extend the following offer of employment as Chief Financial Officer,
and to have you join our growing organization. We feel you will complement our growth initiatives and that OPTIMIZERx/SampleMD
will provide you an environment of personal challenge and opportunity.

 

In
return for applying your expertise and services, we offer the following compensation package:

 

Starting
Salary: $125,000 annually

Bonus:
See Details in Employment Agreement

Benefits: Full Health and Dental

  

Additionally,
we are pleased to award, upon your acceptance, 100,000 OPRx publicly traded stock options.

(50%
vested at year one anniversary date and remainder vested at year two anniversary date.)

 

Within
this package you will find an Employment Agreement further outlining the highlights and terms of employment with OPTIMIZERx. Upon
review and acceptance, please sign and return to David Lester

 

Doug,
we are excited to extend this offer and to having you join us. The future is very promising, the healthcare industry is growing
rapidly, and we are in the midst of some very exciting times. We know that your talents and expertise will certainly augment our
capabilities and services.

 

I
look forward to your favorable response and if you have any further questions please do not hesitate to contact me at any time.

 

 

 

Best
Regards,

 

 

 

/s/
H. David Lester

H.
David Lester

Chief
Operations Officer

    	 

    	 

    

 

EMPLOYMENT
AGREEMENT

 

THIS
AGREEMENT made and entered into this May 12, 2014, by and between OptimizeRx Corporation, a Nevada Company, hereinafter referred
to as “Employer” and Douglas Baker, hereinafter referred to as the “Employee”.

 

Recitals

The
Employer is engaged in the business of Pharmaceutical marketing, sales, and product integration, and desires the Chief Financial
Officer

 

IT
IS THEREFORE AGREED:

 

Term
of Employment

The
Employer hereby employs the Employee and the Employee hereby accepts employment with the Employer beginning on May 19. 2014.

 

Duties
of Employee

 

The
Chief Financial Officer will oversee all finance, accounting, forecasting, budgeting, treasury, tax, SEC compliance and corporate
insurance functions at OPTIMIZERx Corporation. In addition, this role will oversee the HR, legal, administrative and facilities
efforts at OPTIMIZERx Corporation. This role directs all financial activities and advises and assists the CEO and Executive Management
Team in meeting or exceeding the overall financial and strategic objectives of the Company. The CFO is responsible for providing
strategic leadership for the company by working with the Executive Management Team to establish long-range goals, strategies,
plans and policies, along with providing leadership and management for Corporate Administration and Human Resources.

 

Essential
Duties & Responsibilities

 

		•	Define
                                         standards, policies, procedures, measures, and organizational enhancements to meet company
                                         goals for finance. 

		•	Prepare
                                         long range financial forecasts by working collaboratively with other management team
                                         members. 

		•	Lead
                                         the effort in the planning and preparation of the annual budget. 

		•	Regularly
                                         monitor and work closely with management in taking timely action to ensure that budgets
                                         and financial plans stay within approved levels. 

		•	Manage
                                         all accounts receivables and accounts payable activities and monitor all receivables
                                         and collections

		•	Insure
                                         the accounting of revenues and expenses are performed in an accurate, efficient and timely
                                         manner in conformity with GAAP and SEC compliance. 

		•	Prepare
                                         and deliver external audits and filing of quarterly and year end SEC filings, tax return
                                         and ensure proper maintenance of accounting records and documentation in compliance with
                                         statutory requirements and Company policies. 

		•	Manage
                                         the daily cash balance and invest excess funds to achieve the most lucrative rate consistent
                                         with Company policy. 

		•	Prepare
                                         monthly financial reports and related analyses in accordance with GAAP on a timely basis.
                                         

		•	Assist
                                         in the preparation of business plans and financial forecasting for other ventures of
                                         or being considered by the Company. 

		•	Prepare
                                         materials for Board meetings. 

		•	Other
                                         duties may be assigned. 

    	2

    	 

    

 

III.
Supervisory Responsibilities

 

Initially
this position is a one of an individual contributor and is a hands on position to execute the accounting needs for the company.
The position is expected to grow so the individual manages a team of 1-2 employees who are responsible for the coordination and
execution of the various functions performed in the Finance, HR, and Administrative Groups. Directly supervises nonsupervisory
employees

 

Engaging
in Other Employment

The
Employee shall devote his entire productive time, ability, and attention during the normal business hours to the business of the
Employer. The Employee shall not, during the term of this Agreement, directly or indirectly, render any services of a business,
commercial, or a professional nature, whether for compensation or otherwise, to any person or organization which competes, directly
or indirectly, with the business of the employer, without the prior written consent of the Employer.

 

Compensation

As
compensation for services rendered under this Agreement, the Employee shall be entitled to receive from the Employer a salary
of $ 125,000 per year, payable in semi-monthly installments in which such payment becomes due, prorated for any partial employment
period

 

Bonus

As
a member of the Executive Management Team the Chief Financial Officer will be eligible for bonuses based upon agreed and approved
individual and corporate MBO’s. 

 

Employee
Benefit Plans

The
Employee shall be entitled to participate in any qualified pension plan, qualified profit-sharing plan, medical or dental reimbursement
plan, group term life insurance plan, or any other employee benefit plan which is presently existing or which may be established
in the future by the Employer. Such right to participation shall be in accordance with the terms of the particular plans involved.

 

Paid
Vacations

The
Employee shall immediately have an annual vacation leave of 3 weeks paid vacation. When your third year of service is completed
an additional week of vacation will be added. The time for such vacation shall be selected by the Employee, but must be approved
by the Employer. 

 

Paid
Sick Leave

The
Employee shall be entitled to 3 days per year as sick leave with full pay.

 

Business
Expenses

The
Employer, in accordance with the rules and regulations that it may issue from time to time, shall reimburse the Employee for business
expenses properly incurred during the performance of his duties.

    	3

    	 

    

 

Termination
of Employment 

 

“At
Will” Employment

Employee’s
employment with Employer is “at will.” “At will” is defined as allowing either Employee or Employer to
terminate the Agreement at any time, for any reason permitted by law, with or without cause and with or without notice.

  

COVENANTS

 

		A.	Non-Disclosure
                                         of Trade Secrets, Customer Lists and Other Proprietary Information

Employee
agrees not to use, disclose or communicate, in any manner, proprietary information about Employer, its operations, clientele,
or any other proprietary information, that relate to the business of Employer. This includes, but is not limited to, the names
of Employer’s customers, its marketing strategies, operations, or any other information of any kind which would be deemed
confidential or proprietary information of Employer

 

To
the extent Employee feels that they need to disclose confidential information, they may do so only after being authorized to so
do in writing by Employer.

 

B.
Non-Solicitation Covenant

Employee
agrees that for a period of one year following termination of employment, for any reason whatsoever, Employee will not solicit
customers or clients of Employer. By agreeing to this covenant, Employee acknowledges that their contributions to Employer are
unique to Employer’s success and that they have significant access to Employer’s trade secrets and other confidential
or proprietary information regarding Employer’s customers or clients.

 

C.
Non-Recruit Covenant

Employee
agrees not to recruit any of Employer’s employees for the purpose of any outside business either during or for a period
of one year after Employee’s tenure of employment with Employer. Employee agrees that such effort at recruitment also constitutes
a violation of the non-solicitation covenant set forth above.

 

D.
Adherence to Employer's Policies, Procedures, Rules and Regulations

Employee
agrees to adhere by all of the policies, procedures, rules and regulations set forth by the Employer. These policies, procedures,
rules and regulations include, but are not limited to, those set forth within the Employee Handbook, any summary benefit plan
descriptions, or any other personnel practices or policies or Employer. To the extent that Employer’s policies, procedures,
rules and regulations conflict with the terms of this Agreement, the specific terms of this Agreement will control.

 

Severance
Pay

In
the event of the termination of this Agreement prior to the completion of the term of the employment specified herein, the Employee
shall be entitled to the compensation earned by him prior to the date of termination as provided for in this Agreement, computed
prorated up to and including that date.

 

Amendment
and Waiver

Any
provision of this Agreement may be altered or amended by a written document signed by both parties hereto setting forth such alteration
or amendment without affecting the obligations created by the other provisions of this Agreement. The Employer and the Employee
agree that the failure to enforce any provision or obligation under this Agreement shall not constitute a waiver thereof or serve
as a bar to the subsequent enforcement of such provision or obligation or any other provision or obligation under this Agreement. 

    	4

    	 

    

 

Survival
of Covenants

This
Agreement shall be binding upon any successors or heirs or representatives of the parties hereto. The restrictive covenants and
promises of the Employee contained in this Agreement shall survive any termination or rescission of this Agreement unless the
Employer executes a written agreement specifically releasing the Employee from such covenants.

 

Governing
Law

This
Agreement is to be construed in accordance with the laws of the State of Michigan. 

 

 

Employer:

 

 

/s/
H. David Lester

H.
David Lester – Chief Operating Officer

 

Employee:

 

/s/
Douglas P. Baker 

Douglas
P. Baker

    	503.31.14 Exhibit 4.2 JoindertoStockholders_Agreement

Exhibit 4.2
JOINDER
TO THE
EIGHTH AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT
OF
FIVE9, INC.

April 1, 2014

This Joinder (the “Joinder”) to the Eighth Amended and Restated Stockholders’ Agreement dated October 28, 2013, as amended to date, by and among Five9, Inc., a Delaware corporation (the “Company”), and the other signatories thereto (the “Stockholders’ Agreement”), is made and entered into as of April 1, 2014, between the Company and ATEL Ventures, Inc., as Trustee (the “Warrant Holder”).  All capitalized terms used herein without definition shall have the meanings ascribed to them in the Stockholders’ Agreement.
WHEREAS, the Warrant Holder is a holder of warrants issued on February 26, 2010 and June 30, 2010 (the “Warrants”) to purchase shares (the “Shares”) of the Company’s Series A-2 Preferred Stock, par value $0.001 per share (the “Preferred Stock”);
WHEREAS, pursuant to Section 4(d) of the Warrants, the Shares shall have certain registration rights as set forth in the Stockholders’ Agreement; 
WHEREAS, the Company’s board of directors and the holders of at least sixty percent of the Registrable Securities (as defined in the Stockholders’ Agreement) have consented to making the Warrant Holder a party to the Stockholders’ Agreement for the purpose of receiving the registration rights in accordance with Section 4(d) of the Warrants; and
WHEREAS, in connection with becoming a party to the Stockholders’ Agreement, the Warrant Holder will execute the lock-up agreement attached hereto as Exhibit A.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
1.    By executing this Joinder, the definition of “Holder” in Section 1(h) of the Stockholders’ Agreement is hereby amended to include Warrant Holder who shall become a party to the Stockholders’ Agreement and shall have all the rights, including the right to cause the Company to register its Registrable Securities, and related obligations of a "Holder" thereunder, and the definition of “Registrable Securities” set forth in Section 1(o) of the Stockholders’ Agreement is hereby amended to include all the shares of Common Stock acquirable upon exercise of the Warrants..
2.    This Joinder may be executed in any number of counterparts, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one and the same instrument.
[Signature Page Follows]

        

IN WITNESS WHEREOF, the parties have executed this Joinder as of the date first written above.

	
		
	FIVE9, INC. 

	 
	 

	By: 
	 /s/ David Hill

	 
	David Hill

	 
	Vice President, Finance

        

	
	
	“HOLDER”

	 

	ATEL Ventures, Inc., as Trustee

	/s/ Paritosh K. Choksi

	Name:  Paritosh K. Choksi 
Title:    Executive Vice President

        

Exhibit A
Lock-Up Agreement

LOCK-UP AGREEMENT
________ __, 2014
J. P. MORGAN SECURITIES LLC 
BARCLAYS CAPITAL INC.
As Representatives of  
the several Underwriters listed in  
Schedule 1 to the Underwriting 
Agreement referred to below
c/o J. P. Morgan Securities LLC 
383 Madison Avenue 
New York, NY 10179
c/o Barclays Capital Inc. 
745 Seventh Avenue 
New York, New York 10019
Re:    Five9, Inc. --- Public Offering
Ladies and Gentlemen:
The undersigned understands that you, as Representatives of the several Underwriters, propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Five9, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the “Underwriters”), of Common Stock (as defined below) of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
In consideration of the Underwriters’ agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of J. P. Morgan Securities LLC and Barclays Capital Inc., on behalf of the Underwriters, the undersigned will not, during the period ending 180 days after the date of the prospectus relating to the Public Offering (the “Prospectus”), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock, $0.001 par value per share, of the Company (the “Common Stock”) or any securities directly or indirectly convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a 

stock option or warrant) (collectively, the “Equity Securities”), or publicly disclose the intention to make any offer, sale, pledge or disposition, (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise or (3) make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock, in each case other than:
(A) the Securities to be sold by the undersigned pursuant to the Underwriting Agreement;
(B) sales of Equity Securities acquired in open market transactions after the date of the Public Offering;
(C) transfers of Equity Securities as a bona fide gift or gifts or by will or intestacy;
(D) transfers of Equity Securities pursuant to domestic relations or court orders;
(E) if the undersigned is an individual, transfers of Equity Securities to any trust for the direct or indirect benefit of the undersigned or the family of the undersigned, or limited partnerships the partners of which are the undersigned and/or the family members of the undersigned, in each case for estate planning purposes;
(F) if the undersigned is a trust, distributions of Equity Securities to its beneficiaries;
(G) if the undersigned is a corporation, limited liability company, partnership or other entity, distribution of shares of Equity Securities to members, stockholders, partners, subsidiaries or affiliates of the undersigned or to any investment fund or other entity that controls or manages, is under common control with or is controlled or managed by the undersigned;
(H) sales or transfers of Equity Securities to the Company solely in connection with the “cashless” exercise of Company stock options or warrants for the purpose of exercising such stock options or warrants (provided that any remaining Common Stock received upon such exercise will be subject to the restrictions provided for under this agreement);
(I) transfers pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction involving a Change of Control (as defined below) of the Company, provided that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the securities held by the undersigned shall remain subject to the provisions of this agreement;
(J) transfers in connection with the conversion of the outstanding preferred stock of the Company into shares of Common Stock or the exercise or exchange of Equity Securities of the Company into shares of Common Stock or preferred stock of the Company (provided that any Common Stock or preferred stock, as the case may be, received upon such conversion, exercise or exchange will be subject to the restrictions provided for under this agreement);

(K) repurchases of Equity Securities by the Company pursuant to agreements under which the Company has the option to repurchase such Equity Securities or a right of first refusal with respect to transfers of such shares or securities;
(L) the establishment of a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for the transfer of shares of Common Stock, provided that (i) such plan does not provide for the transfer of shares of Common Stock during the 180-day period, and (ii) no filing by any party under the securities laws or other public announcement shall be voluntarily made in connection with the establishment of such plan, and to the extent a public announcement or filing by any party is required under the securities laws regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the 180-day period;
provided that in the case of any transfer or distribution pursuant to clauses (C) through (G), each donee, heir or distributee shall execute and deliver to the Representatives a lock-up letter in the form of this agreement; and provided, further, that in the case of any transfer or distribution pursuant to clauses (C) through (H), no filing by any party (donor, donee, transferor or transferee) under the Exchange Act, or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the 180-day period referred to above).  If the undersigned is an officer or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any Company-directed Securities the undersigned may purchase in the Public Offering.
“Change of Control” shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the Underwriters pursuant to the Public Offering), of securities of the Company if, after such transfer, such person or group of affiliated persons would hold a majority or more of the outstanding voting securities of the Company (or the surviving entity).
If the undersigned is an officer or director of the Company, (i) J.P. Morgan Securities LLC and Barclays Capital Inc. on behalf of the Underwriters agree that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of Common Stock by such officer or director, J.P. Morgan Securities LLC and Barclays Capital Inc. on behalf of the Underwriters will notify the Company of the impending release or waiver, and (ii) the Company will agree or has agreed in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at least two business days before the effective date of the release or waiver.  Any release or waiver granted by J.P. Morgan Securities LLC and Barclays Capital Inc. on behalf of the Underwriters hereunder to any such officer or director shall only be effective two business days after the publication date of such press release.  The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer not for consideration and (b) the 

transferee has agreed in writing to be bound by the same terms described in this letter to the extent and for the duration that such terms remain in effect at the time of the transfer.
In the event that either of the Representatives withdraws from or declines to participate in the Public Offering, all references to the Representatives contained in this agreement shall be deemed to refer to the sole Representative that continues to participate in the Public Offering (the “Sole Representative”), and, in such event, any written consent, waiver or notice given or delivered in connection with this agreement by the Sole Representative shall be deemed to be sufficient and effective for all purposes under this agreement.
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this agreement. 
The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this agreement.  All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned.
The undersigned understands that, if (i) the Underwriting Agreement does not become effective by June 30, 2014, (ii) after becoming effective, the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder, or (iii) the Company notifies the Representatives, in writing, prior to the execution of the Underwriting Agreement, that it does not intend to proceed with the Public Offering, then as of such relevant date, this agreement shall terminate and the undersigned shall be released from all obligations under this agreement.  The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this agreement.
This agreement and any claim, controversy or dispute arising under or related to this agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof.
Very truly yours,

By:         
    Name: 
    Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}]]